Cytosorbents CorpCytosorbents Corp - ESG Rating & Company Profile powered by AI

Industry Group:Advanced Medical Equipment & Technology

The webpage is a free Environmental, Social and Governance assessment for Cytosorbents Corp. This report of Cytosorbents Corp leverages data points from across the internet and also from available disclosures by Cytosorbents Corp. If you work at Cytosorbents Corp and you would like to licence your ESG aseessment, please get in touch.

Cytosorbents Corp in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 1.3, social score of 4.6 and governance score of 6.0.

SDG Transparency Score for Cytosorbents Corp 
Low
0 - 3

4.3

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Cytosorbents Corp 
1.3

Environmental

4.6

Social

6.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Medtronic PLC
9.3
High
2Edwards Lifesciences Corp
8.3
High
153Nanalysis Scientific Corp
4.4
High
153Resonance Health Ltd
4.4
High
161Cytosorbents Corp
4.3
High
161Stereotaxis Inc
4.3
High
163El En SpA
4.2
High
.........
349WaferGen Bio-Systems Inc
0.0
Low
349ZELTIQ Aesthetics Inc
0.0
Low
.........
View the full peer group of 456 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Cytosorbents Corp have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Cytosorbents Corp report the average age of the workforce?

LockedSign up for free to unlock

Does Cytosorbents Corp reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose cybersecurity risks?

LockedSign up for free to unlock

Does Cytosorbents Corp offer flexible work?

LockedSign up for free to unlock

Does Cytosorbents Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Cytosorbents Corp conduct supply chain audits?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Cytosorbents Corp conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose water use targets?

LockedSign up for free to unlock

Does Cytosorbents Corp have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Cytosorbents Corp have a product recall in the last two years?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose incidents of discrimination?

LockedSign up for free to unlock

Does Cytosorbents Corp allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Cytosorbents Corp issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose parental leave metrics?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Cytosorbents Corp support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Cytosorbents Corp reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Cytosorbents Corp involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose its waste policy?

LockedSign up for free to unlock

Does Cytosorbents Corp report according to TCFD requirements?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose energy use targets?

LockedSign up for free to unlock

Does Cytosorbents Corp disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Cytosorbents Corp have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Cytosorbents Corp
These potential risks are based on the size, segment and geographies of the company.

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove toxic chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Sorry!

Failed to process!